Trial intelligence / Profile preview

Argatroban + prostacyclin vs unfractionated heparin + prostacyclin during continuous venovenous haemodiafiltration (crossover trial)

2008-000042-31Phase 4Completed

Sponsor
University Clinic for Anesthesiology, Intensive Care Medicine and Pain Therapy
Start
Aug 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of argatroban in acute kidney failure (AKF), end-stage kidney disease (ESKD) and Acute Kidney Injury requiring Renal Replacement Therapy (AKI-RRT) (2 arms), sponsored by University Clinic for Anesthesiology, Intensive Care Medicine and Pain Therapy. Primary endpoint: Filter lifespan during continuous venovenous haemodiafiltration. Started Aug 2008; status: completed.

02

Drugs

argatroban
03

Conditions

acute kidney failure (AKF)end-stage kidney disease (ESKD)Acute Kidney Injury requiring Renal Replacement Therapy (AKI-RRT)

Beyond the preview

Go deeper on 2008-000042-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-000042-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call